New IV drug trial aims to help dialysis patients sleep better by relieving debilitating itch
NCT ID NCT07380113
Summary
This study aims to see if a new intravenous (IV) drug works better than an existing oral pill at improving sleep quality for people on dialysis who suffer from severe, chronic itching caused by their kidney disease. Researchers will compare the two treatments in 50 participants over four weeks, primarily using a sleep quality questionnaire. The study will also check the safety of the new IV drug and see if it improves patients' overall quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL INSUFFICIENCY, CHRONIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.